Pasithea Therapeutics Corp
Pasithea Therapeutics Corp is a biotechnology company based in Miami Beach, Florida, focused on the discovery, research, and development of innovative treatments for central nervous system disorders and RASopathies. The company's lead therapeutic candidate, PAS004, is a next-generation macrocyclic MEK inhibitor aimed at addressing various indications, including neurofibromatosis type 1-associated plexiform neurofibromas and certain oncology conditions.
With a commitment to advancing healthcare solutions, Pasithea Therapeutics is actively engaged in clinical trials and has reported positive pharmacodynamic results from its ongoing Phase 1 clinical trial. The company also participates in significant industry events, such as the Annual Meeting of the American Society for Clinical Oncology, to showcase its advancements and foster collaboration within the medical community.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.